Methimazole agranulocytosis treated with recombinant human granulocyte colony stimulating factor.
Moroni
M
M
Istituto di Terapia Medica, Università, IRCCS Policlinico San Matteo, Pavia.
Tommaselli
F
F
Casagranda
I
I
Rizzi
E
E
Porta
C
C
D000380:Agranulocytosis / Q000139:chemically induced* / Q000188:drug therapy*; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D006111:Graves Disease / Q000188:drug therapy; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008713:Methimazole / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D008713:Methimazole